Today, Neurallys announced that it has raised €750,000 in funds from the Doliam group and HACFutur to be plowed into accelerating development for its connected implant designed for use in thousands of hydrocephalus patients.
Hydrocephalus is a severe neurological abnormality that occurs in newborns or as a result of a tumor, stroke, aneurysm, head injury or meningitis. Incubated at the Institut du Cerveau et de la Moelle épinière-ICM, the start-up aims to:
- Improve quality of life for hydrocephalus patients
- Expand care and treatment options
- Develop a personalized approach to medicine
To fulfil its goals, Neurallys has developed a unique solution: a ‘barometer’ that can be used to measure and record intracranial pressure continuously. This minimally-invasive sensor is implanted in front of the valve located inside the shunt fitted on all patients living with the condition, and will finally enable professionals to collect precious information needed for diagnosis and follow-up, as well as limit unnecessary hospitalization and interventions and prevent equipment malfunctions, which can have serious repercussions.
An indisputable boon for patient health and safety, and an irrefutable asset for hospitals financially. In the short term, the funds raised will see the R&D team grow, with three extra engineers recruited, and will ensure the implant prototype can be finalized for the pre-clinical trial phase based on an acute hydrocephalus model.
“The technology developed by Neurallys is a beacon of hope for outpatient quality of life,” says Agathe, a young woman who has lived with hydrocephalus since birth.
“We deal with hydrocephalus cases every day, and we’re lacking the data needed to better understand, prevent and treat it. We’re often required to take emergency action, because we have no effective way of measuring it in an everyday context: for neurosurgeons, this innovative technology is a dream come true!” Prof. Philippe Cornu, Head of the Neurosurgery Department at the Hôpital de la Pitié-Salpêtrière and the Hôpital Necker Enfants Malades in Paris.
Contact: Philippe Auvray-CEO. philippe.auvray@neurallys.com. Tel. +33(0)1 57 27 42 74 Cell +33(0)6 47 74 96 45
